Relevance of rapid, reliable and low-cost diagnostics in the current COVID-19 pandemic

<p>COVID-19 virus has emerged as a global pandemic. This zoonotic virus has known to be originated in China, which within few weeks has spread across the world. The virus has infected millions of people and lakhs have died due to this virus. It has high transmissibility with a reproductive num...

Full description

Saved in:
Bibliographic Details
Main Authors: Relevance of rapid (Author), reliable (Author), low-cost diagnostics in the current (Author)
Format: Book
Published: Global Journal of Clinical Virology - Peertechz Publications, 2020-06-26.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 peertech__10_17352_gjcv_000007
042 |a dc 
100 1 0 |a Relevance of rapid  |e author 
700 1 0 |a  reliable  |e author 
700 1 0 |a low-cost diagnostics in the current  |e author 
245 0 0 |a Relevance of rapid, reliable and low-cost diagnostics in the current COVID-19 pandemic 
260 |b Global Journal of Clinical Virology - Peertechz Publications,   |c 2020-06-26. 
520 |a <p>COVID-19 virus has emerged as a global pandemic. This zoonotic virus has known to be originated in China, which within few weeks has spread across the world. The virus has infected millions of people and lakhs have died due to this virus. It has high transmissibility with a reproductive number (Ro) of 2.2. Many cases are reported asymptomatic, hence making the control of the infection a herculean task. Many countries have resorted to lockdowns to flatten the curve of infection, leading to shutting of many businesses and pushing the global economy into severe recession. India's GDP is said to be in negative territory, as expected by Reserve Bank of India. The review summarizes about the global efforts that are been made to develop novel, rapid, reliable and affordable molecular diagnostic assays such as nucleotide and antigen-based detection assays and serological assays. Many of them are under developing stage and few have received an Emergency Use Authorisation (EUA) or Conformite Europeene (CE) certification for their application in different hospitals and clinical settings. For confirmatory diagnosis, such category of molecular diagnostics needs to replace the presently employed Real-Time PCR assays that are high in installation, testing cost and expertise intensive normally resulting in delay for obtaining results. These limitations do not permit an exhaustive testing needed under the current pandemic situation. The new category of rapid, reliable, low cost diagnostic once deployed would effectively help in arresting the community transmission of the disease to a larger extent, thereby easing of lockdown situations and contributes towards revival of economy.</p> 
540 |a Copyright © Relevance of rapid et al. 
546 |a en 
655 7 |a Review Article  |2 local 
856 4 1 |u https://doi.org/10.17352/gjcv.000007  |z Connect to this object online.